Sagittarius Life Science Corp (TPEX:3205)

Sagittarius Life Science Statistics

Total Valuation

TPEX:3205 has a market cap or net worth of TWD 3.53 billion. The enterprise value is 3.38 billion.

Market Cap	3.53B
Enterprise Value	3.38B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:3205 has 67.55 million shares outstanding. The number of shares has increased by 65.53% in one year.

Current Share Class	67.55M
Shares Outstanding	67.55M
Shares Change (YoY)	+65.53%
Shares Change (QoQ)	-0.68%
Owned by Insiders (%)	37.77%
Owned by Institutions (%)	n/a
Float	36.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.21
PB Ratio	3.38
P/TBV Ratio	3.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-68.27
EV / Sales	9.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-92.84

Financial Position

The company has a current ratio of 31.84, with a Debt / Equity ratio of 0.00.

Current Ratio	31.84
Quick Ratio	6.28
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-860.40

Financial Efficiency

Return on equity (ROE) is -6.81% and return on invested capital (ROIC) is -10.32%.

Return on Equity (ROE)	-6.81%
Return on Assets (ROA)	-4.60%
Return on Invested Capital (ROIC)	-10.32%
Return on Capital Employed (ROCE)	-5.59%
Weighted Average Cost of Capital (WACC)	8.43%
Revenue Per Employee	3.09M
Profits Per Employee	-442,536
Employee Count	112
Asset Turnover	0.43
Inventory Turnover	14.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.53% in the last 52 weeks. The beta is 0.76, so TPEX:3205's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+57.53%
50-Day Moving Average	50.34
200-Day Moving Average	49.80
Relative Strength Index (RSI)	60.70
Average Volume (20 Days)	97,546

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:3205 had revenue of TWD 346.08 million and -49.56 million in losses. Loss per share was -0.92.

Revenue	346.08M
Gross Profit	57.71M
Operating Income	-58.51M
Pretax Income	-49.88M
Net Income	-49.56M
EBITDA	-48.16M
EBIT	-58.51M
Loss Per Share	-0.92

Balance Sheet

The company has 151.55 million in cash and 385,000 in debt, with a net cash position of 151.16 million or 2.24 per share.

Cash & Cash Equivalents	151.55M
Total Debt	385,000
Net Cash	151.16M
Net Cash Per Share	2.24
Equity (Book Value)	1.04B
Book Value Per Share	15.54
Working Capital	801.46M

Cash Flow

In the last 12 months, operating cash flow was -36.05 million and capital expenditures -404,000, giving a free cash flow of -36.45 million.

Operating Cash Flow	-36.05M
Capital Expenditures	-404,000
Depreciation & Amortization	10.34M
Net Borrowing	-5.00M
Free Cash Flow	-36.45M
FCF Per Share	-0.54

Margins

Gross margin is 16.68%, with operating and profit margins of -16.91% and -14.32%.

Gross Margin	16.68%
Operating Margin	-16.91%
Pretax Margin	-14.41%
Profit Margin	-14.32%
EBITDA Margin	-13.92%
EBIT Margin	-16.91%
FCF Margin	n/a

Dividends & Yields

TPEX:3205 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-65.53%
Shareholder Yield	-65.53%
Earnings Yield	-1.40%
FCF Yield	-1.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 17, 2016. It was a forward split with a ratio of 1.048659339.

Last Split Date	Aug 17, 2016
Split Type	Forward
Split Ratio	1.048659339

Scores

TPEX:3205 has an Altman Z-Score of 47.11 and a Piotroski F-Score of 2.

Altman Z-Score	47.11
Piotroski F-Score	2